Abstract
Interstitial lung disease (ILD) associated with polymyositis/dermatomyositis (ILD-PM/DM), including amyopathic dermatomyositis (ADM), is recognized as an important condition because it frequently causes death, despite intensive therapy with high-dose corticosteroid and immunosuppressive agents, such as cyclosporine A and cyclophosphamide. Intravenous immunoglobulin therapy (IVIG) has shown efficacy for myopathy associated with PM/DM, but its usefulness for ILD-PM/DM is unclear. This study was designed to investigate the efficacy of IVIG for refractory ILD-PM/DM. A review was made of medical charts of five patients (2 men and 3 women) who were treated with IVIG for refractory ILD-PM/DM resistant to high-dose corticosteroid and cyclosporine A and/or cyclophosphamide. One patient had acute ILD-PM and four patients had acute ILD-ADM. Of the five patients, one patient with ILD-PM and one patient with ILD-ADM survived. No adverse reactions were seen due to IVIG treatment. There were no critical differences in the clinical parameters and clinical courses between survivors and nonsurvivors. IVIG treatment is safe and could be an effective salvage therapy for refractory ILD-PM/DM in certain cases, suggesting that further controlled trials are worthwhile.
References
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of 2 parts). N Engl J Med 292:344–347
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of 2 parts). N Engl J Med 292:403–407
Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387–408. doi:10.1016/S0733-8635(02)00021-9
Euwer RL, Sontheimer RD (1993) Amyopathic dermatomyositis: a review. J Invest Dermatol 100:124S–127S. doi:10.1111/1523-1747.ep12356896
Kagen LJ (1995) Amyopathic dermatomyositis. Arch Dermatol 131:1458–1459. doi:10.1001/archderm.131.12.1458
Erel A, Toros P, Tokcaer AB, Gurer MA (2000) Amyopathic dermatomyositis. Int J Dermatol 39:771–773. doi:10.1046/j.1365-4362.2000.00047-5.x
Olsen NJ, Park JH, King LE Jr (2001) Amyopathic dermatomyositis. Curr Rheumatol Rep 3:346–351. doi:10.1007/s11926-001-0039-9
Caproni M, Cardinali C, Parodi A, Giomi B, Papini M, Vaccaro M, Marzano A, De Simone C, Fazio M, Rebora A, Fabbri P (2002) Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology. Arch Dermatol 138:23–27. doi:10.1001/archderm.138.1.23
Dalkas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982. doi:10.1016/S0140-6736(03)14368-1
Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 63:297–301. doi:10.1136/ard.2003.006122
Schnable A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32:273–284. doi:10.1053/sarh.2002.50012
Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47:614–622. doi:10.1002/art.10794
Hirakata M, Nagai S (2000) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 12:501–508. doi:10.1097/00002281-200011000-00005
Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T (1987) Interstitial lung disease in dermatomyositis: clinicopathlogical study. J Rheumatol 14:102–107
Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I (1999) Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 26:1527–1533
Sontheimer RD, Miyagawa S (2003) Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis. J Am Acad Dermatol 48:797–798. doi:10.1067/mjd.2003.199
Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32:1719–1726
Miyake S, Ohtani Y, Sawada M, Inase N, Miyazaki Y, Takano S, Miyasaka N, Yoshizawa Y (2002) Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis 19:128–133
Dalkas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993–2000. doi:10.1056/NEJM199312303292704
Cherin P, Pelletier S, Teixeria P, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S (2002) Result and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 46:467–474. doi:10.1002/art.10053
Danieli MG, Malcangi G, Palmieri C, Logullo F, Salvi A, Piani M, Danieli G (2002) Cyclosporine A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. Ann Rheum Dis 61:37–41. doi:10.1136/ard.61.1.37
Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, Hashimoto D, Sato J, Toyoshima M, Hashizume H, Chida K (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28:1005–1012. doi:10.1183/09031936.06.00038806
Miyazaki E, Ando M, Muramatsu T, Fukami T, Matsuno O, Nureki S, Ueno T, Tsuda T, Kumamoto T (2007) Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol 26:436–439. doi:10.1007/s10067-005-0147-4
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suzuki, Y., Hayakawa, H., Miwa, S. et al. Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis. Lung 187, 201–206 (2009). https://doi.org/10.1007/s00408-009-9146-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-009-9146-6